RajKMaturiMD

Clinical Trials

• Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) Start of enrollment: 2010 Jun 01

  Completed

  Phase 2, Phase 3

• Single Site, Masked, Randomized, Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein Occlusion Start of enrollment: 2010 Mar 01

  Completed

  Phase 4

• Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema Start of enrollment: 2011 Mar 01

  Completed

  Phase 4

• Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control Start of enrollment: 2011 Oct 01

  Completed

  Phase 3

• Phase II Combination Steroid and Anti-VEGF for Persistent DME Start of enrollment: 2014 Feb 01

  Completed

  Phase 2

• Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema Start of enrollment: 2014 Jan 01

  Completed

  Phase 4

• A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DME Start of enrollment: 2014 Jul 18

  Completed

  Phase 1

• Sirolimus in Conjunction With Eylea vs Eylea Alone for Exudative AMD Start of enrollment: 2016 Apr 01

  Completed

  Phase 2

• HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia Start of enrollment: 2020 Jun 12

  Completed

  Phase 1, Phase 2

• Join now to see all